RAPID ASSAY FOR HIV-1 ANTIBODIES IN SALIVA

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$468,218.00
Award Year:
1991
Program:
SBIR
Phase:
Phase II
Contract:
n/a
Agency Tracking Number:
11060
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Epitope Inc.
15425-e Sw Koll Parkway, Beaverton, OR, 97006
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
() -
Business Contact:
() -
Research Institution:
n/a
Abstract
THERE IS A NEED FOR AN HIV-I ANTIBODY TEST THAT IS SPECIFICALLY DESIGNED FOR FIELD USE WITH SALIVA AND THAT IS RAPID, ACCURATE, CONVENIENT, AND INEXPENSIVE. SUCH A TEST WOULD BE ESPECIALLY VALUABLE IN WORK WITH I.V. DRUG ABUSERS AND PROSTITUTES, WHERE TIME WITH THE PATIENT IS BRIEF AND FOLLOWUP IS DIFFICULT. USE OF SALIVA ALLOWS FOR A RAPID "ON THE STREET" TEST, BECAUSE THE TIME, PRECAUTIONS, AND EQUIPMENT ATTENDANT WITH BLOOD DRAWING AND SERUM PREPARATION ARE ELIMINATED. THE AVOIDANCE OF NEEDLES MAKES THE ASSAY PARTICULARLY VALUABLE IN TESTING PRISON POPULATIONS. THIS PROJECT USES A SALIVA TEST WITH A COLUMN FORMAT TO CONCENTRATE THE ANTIBODIES FROM 1 TO 5 ML OF SALIVA ONTO A SMALL AMOUNT OF PROTEIN A-AGAROSE GEL. HAVING DEMONSTRATED THE ACCURACY AND SPEED OF THE TEST WITH SERUM AND SALIVA SAMPLES, EPITOPE, INC., NOW INTENDS TO EMBARK ON LARGER SCALE TESTING WITH SEVERAL HUNDRED MATCHED SALIVA AND SERUM SAMPLES FROM CONTROL AND HIV-I-INFECTED SUBJECTS. FURTHER IMPROVEMENT OF THE FORMATTING AND SENSITIVITY OF THE TEST WILL PREPARE IT FOR COMMERCIALIZATION.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government